Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices 13989 

available. However, the meeting will be 

recorded and posted on the CPSC’s Web 

site. 

FOR FURTHER INFORMATION CONTACT: 

Michael Babich, Directorate for Health 

Sciences, U.S. Consumer Product Safety 

Commission, Bethesda, MD 20814; 

telephone (301) 504–7253; e-mail 

mbabich@cpsc.gov. 

SUPPLEMENTARY INFORMATION: Section 

108 of the CPSIA permanently prohibits 

the sale of any ‘‘children’s toy or child 

care article’’ containing more than 0.1 

percent of each of three specified 

phthalates—di-(2-ethylhexyl) phthalate 

(DEHP), dibutyl phthalate (DBP), and 

benzyl butyl phthalate (BBP). Section 

108 of the CPSIA also prohibits, on an 

interim basis, the sale of any ‘‘children’s 

toy that can be placed in a child’s 

mouth’’ or ‘‘child care article’’ containing 

more than 0.1 percent of each of three 

additional phthalates—diisononyl 

phthalate (DINP), diisodecyl phthalate 

(DIDP), and di-n-octyl phthalate 

(DNOP). 

Moreover, section 108 of the CPSIA 

requires the Commission to convene a 

CHAP ‘‘to study the effects on children’s 

health of all phthalates and phthalate 

alternatives as used in children’s toys 

and child care articles.’’ The CPSIA 

requires the CHAP to complete an 

examination of the full range of 

phthalates that are used in products for 

children and: 

• Examine all of the potential health 

effects (including endocrine disrupting 

effects) of the full range of phthalates; 

• Consider the potential health effects 

of each of these phthalates, both in 

isolation and in combination with other 

phthalates; 

• Examine the likely levels of 

children’s, pregnant women’s, and 

others’ exposure to phthalates, based 

upon a reasonable estimation of normal 

and foreseeable use and abuse of such 

products; 

• Consider the cumulative effect of 

total exposure to phthalates, from 

children’s products and from other 

sources, such as personal care products; 

• Review all relevant data, including 

the most recent, best available, peerreviewed, scientific studies of these 

phthalates and phthalate alternatives 

that employ objective data-collection 

practices or employ other objective 

methods; 

• Consider the health effects of 

phthalates not only from ingestion but 

also as a result of dermal, hand-tomouth, or other exposure; 

• Consider the level at which there is 

a reasonable certainty of no harm to 

children, pregnant women, or other 

susceptible individuals and their 

offspring, reviewing the best available 

science, and using sufficient safety 

factors to account for uncertainties 

regarding exposure and susceptibility of 

children, pregnant women, and other 

potentially susceptible individuals; and 

• Consider possible similar health 

effects of phthalate alternatives used in 

children’s toys and child care articles. 

The CPSIA contemplates completion 

of the CHAP’s examination within 18 

months of the panel’s appointment. The 

CHAP must review prior work on 

phthalates by the Commission, but the 

prior work is not to be considered 

determinative, as the CHAP’s 

examination must be conducted de 

novo. 

The CHAP must make 

recommendations to the Commission 

which phthalates (or combinations of 

phthalates) in addition to those 

identified in section 108 of the CPSIA 

or phthalate alternatives that the panel 

determines should be prohibited from 

use in children’s toys or child care 

articles or otherwise restricted. The 

CHAP members were selected by the 

Commission from scientists nominated 

by the National Academy of Sciences. 

See 15 U.S.C. 2077, 2030(b). 

The CHAP met previously in April, 

July, and December 2010. The CHAP 

heard testimony from interested parties 

at the July meeting. The March 2011 

meeting will include discussion of the 

CHAP’s progress toward its analysis of 

potential risks from phthalates and 

phthalate substitutes. There will not be 

any opportunity for public comment at 

the March 30–31 meeting. 

Dated: March 10, 2011. 

Todd A. Stevenson, 

Secretary. 

[FR Doc. 2011–6020 Filed 3–14–11; 8:45 am] 

BILLING CODE 6355–01–P 

CORPORATION FOR NATIONAL AND 

COMMUNITY SERVICE 

Information Collection; Submission for 

OMB Review, Comment Request 

AGENCY: Corporation for National and 

Community Service. 

ACTION: Notice. 

SUMMARY: The Corporation for National 

and Community Service (hereinafter the 

‘‘Corporation’’), has submitted a public 

information collection request (ICR) 

entitled the Senior Corps Grant 

Application to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995, 

Public Law 104–13 (44 U.S.C. chapter 

35). Copies of this ICR, with applicable 

supporting documentation, may be 

obtained by calling the Corporation for 

National and Community Service, Ms. 

Angela Roberts, at (202) 606–6822, 

(aroberts@cns.gov). Individuals who use 

a telecommunications device for the 

deaf (TTY–TDD) may call (202) 606– 

3472 between 8:30 a.m. and 5 p.m. 

Eastern time, Monday through Friday. 

ADDRESSES: Comments may be 

submitted, identified by the title of the 

information collection activity, to the 

Office of Information and Regulatory 

Affairs, Attn: Ms. Sharon Mar, OMB 

Desk Officer for the Corporation for 

National and Community Service, by 

any of the following two methods 

within 30 days from the date of 

publication in the Federal Register: 

(1) By fax to: (202) 395–6974, Attention: 

Ms. Sharon Mar, OMB Desk Officer 

for the Corporation for National and 

Community Service; and 

(2) Electronically by e-mail to: 

smar@omb.eop.gov. 

SUPPLEMENTARY INFORMATION: The OMB 

is particularly interested in comments 

which: 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Corporation, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

• Propose ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and 

• Propose ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

through the use of appropriate 

automated, electronic, mechanical, or 

other technological collection 

techniques or other forms of information 

technology, e.g., permitting electronic 

submissions of responses. 

Comments 

A 60-day public comment Notice was 

published in the Federal Register on 

December 14, 2010. This comment 

period ended February 14, 2011. The 

following summarizes the public 

comments received from the Notice 

summary: 

(a) Two commenters supported the 

change and noted that an Executive 

Summary would add minimal burden to 

the application process. (b) Five 

commenters requested more details 

about the Executive Summary, asking 

what an Executive Summary is and 


srobinson on DSKHWCL6B1PROD with NOTICES
13990 Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices 

what information will be required in it. 

The Executive Summary will ask 

respondents to summarize the 

application’s contents. The Corporation 

will provide more details about the 

Executive Summary at the appropriate 

time. (c) One commenter indicated that 

the Corporation underestimated the 

additional time burden added by the 

executive summary. The Corporation 

agrees and has adjusted the estimated 

time accordingly. (d) One commenter 

suggested that the Corporation eliminate 

another part of the application to 

account for the addition of an Executive 

Summary. The Corporation believes that 

the additional burden of an Executive 

Summary will be minimal, and that the 

addition will increase the effectiveness 

and efficiency of the grant review 

process. Therefore, we do not intend to 

remove another portion of the 

application. 

Description: The Corporation seeks to 

renew the current application with one 

modification. The Corporation will ask 

applicants to include an Executive 

Summary to improve the efficiency and 

effectiveness of the peer review process. 

The information collection will 

otherwise be used in the same manner 

as the existing application. The 

Corporation also seeks to continue using 

the current application until the revised 

application is approved by OMB. The 

current application is due to expire on 

May 31, 2011. 

The Senior Corps Grant Application is 

completed by applicant organizations 

interested in sponsoring a Senior Corps 

project. The application is completed 

electronically using the Corporation’s 

web-based grants management system, 

eGrants. 

Type of Review: Renewal. 

Agency: Corporation for National and 

Community Service. 

Title: National Senior Service Corps 

Grant Application. 

OMB Number: 3045–0035. 

Agency Number: SF 424–NSSC. 

Affected Public: Current and 

prospective sponsors of National Senior 

Service Corps Grants. 

Total Respondents: 1,350. 

Frequency: Annually, with 

exceptions. 

Average Time per Response: 

Estimated at 17 hours each for 180 firsttime respondents; 15.5 hours each for 

900 continuation sponsors; 5.5 hours 

each for 270 revisions. 

Estimated Total Burden Hours: 18,495 

hours. 

Total Burden Cost (capital/startup): 

None. 

Total Burden Cost (operating/ 

maintenance): $4,609.50. 

Dated: March 9, 2011. 

Erwin Tan, 

Director, National Senior Service Corps. 

[FR Doc. 2011–6032 Filed 3–14–11; 8:45 am] 

BILLING CODE 6050–$$–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

[Docket ID: DOD–2011–HA–0033] 

Proposed Collection; Comment 

Request 

AGENCY: Office of the Assistant 

Secretary of Defense for Health Affairs, 

DoD. 

ACTION: Notice. 

SUMMARY: In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the Office of the 

Assistant Secretary of Defense for 

Health Affairs announces a proposed 

new public information collection and 

seeks public comment on the provisions 

thereof. Comments are invited on: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed 

information collection; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

information collection on respondents, 

including through the use of automated 

collection techniques or other forms of 

information technology. 

DATES: Consideration will be given to all 

comments received by May 16, 2011. 

ADDRESSES: You may submit comments, 

identified by docket number and title, 

by any of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Federal Docket Management 

System Office, 1160 Defense Pentagon, 

OSD Mailroom 3C843, Washington, DC 

20301–1160. 

Instructions: All submissions received 

must include the agency name, docket 

number and title for this Federal 

Register document. The general policy 

for comments and other submissions 

from members of the public is to make 

these submissions available for public 

viewing on the Internet at http:// 

www.regulations.gov as they are 

received without change, including any 

personal identifiers or contact 

information. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on this 

proposed information collection or to 

obtain a copy of the proposal and 

associated collection instruments, 

please write to Naval Health Research 

Center, DoD Center for Deployment 

Health Research, Department 164, 

ATTN: Tyler C. Smith, MS, PhD, 140 

Sylvester Rd., San Diego, CA 92106– 

3521, or call (619) 553–7593. 

Title; Associated Form; and OMB 

Number: ACAM2000® Myopericarditis 

Registry; OMB Control Number 0720– 

TBD. 

Needs and Uses: The Food and Drug 

Administration required the 

establishment of several Phase IV postlicensure studies to evaluate the longterm safety of ACAM2000® smallpox 

vaccine. Among the required postlicensure studies is the establishment of 

a myopericarditis registry. The 

ACAM2000® Myopericarditis Registry is 

designed to study the natural history of 

myopericarditis following receipt of the 

ACAM2000® vaccine, including 

evaluating factors that may influence 

disease prognosis, thus addressing the 

FDA post-licensure requirement and 

ensuring the continued licensing of this 

vaccine. 

Affected Public: Civilians, former 

Active Duty or active Guard/Reserve in 

the U.S. Military, who received the 

ACACM2000® smallpox vaccine while 

in the military and subsequently 

developed signs or symptoms of 

myopericarditis. 

Annual Burden Hours: 20. 

Number of Respondents: 20. 

Responses per Respondent: 2. 

Average Burden per Response: 30 

minutes. 

Frequency: Semi-annually. 

SUPPLEMENTARY INFORMATION: 

Summary of Information Collection 

Eligible respondents are civilians who 

are former Active Duty or active Guard/ 

Reserve in the U.S. Military that 

received the ACACM2000® smallpox 

vaccine while in the military and 

subsequently developed signs or 

symptoms of myopericarditis. The 

information collected will illuminate 

the natural history of post-vaccine 

myopericarditis and evaluate factors 

that may influence disease prognosis. 

Inclusion of civilians who were 

formerly in the military in addition to 

current military members is imperative 

in order to obtain information on those 

who may have separated from the 

military due to their medical condition. 

Conducting this Registry will ensure the 

continued licensure of this military 

relevant vaccine. 


srobinson on DSKHWCL6B1PROD with NOTICES